Skip to main content

Boehringer Ingelheim Gives $65M to JGU Mainz for Life Sciences

NEW YORK (GenomeWeb News) – The Johannes Gutenberg University Mainz will receive €50 million ($65.4 million) over the next 10 years from the Boehringer Ingelheim Foundation to fund its life sciences activities, the university said on Friday.

The funding will go toward efforts to consolidate JGU's biology program around its Institute of Molecular Biology.

The IMB was established with €100 million in funding from the foundation in 2009, and now JGU said plans for this institute to serve as the basis of its biology activities and faculty.

The German university also said it has plans to construct a new biology research building using additional funding from the state government, JGU said, and to recruit new life sciences faculty members, with the specific aim of supporting young researchers.

IMB's current research efforts include studies involving developmental biology, epigenetics, DNA repair, and similar biomedical areas.

The institute's research capabilities include core facilities that provide services for next-generation sequencing, microarray analysis, bioinformatics, high-end microscopy, and cytometry.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.